Congress legalizes cannabis, expunges convictions, funds drug-war recovery
S. 5022 — Cannabis Administration and Opportunity Act · Filed by Cory Booker (D-NJ) · 16 cosponsors · Introduced Jul 16, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill deschedules cannabis from federal drug law, establishes federal regulatory oversight of cannabis products (tracking, labeling, recordkeeping), funds extensive research on cannabis health effects and impaired driving, and creates a $200+ million reinvestment program to support people harmed by drug war enforcement—including expungement of cannabis convictions, job training, reentry services, and community grants in neighborhoods disproportionately affected by cannabis arrests.
Why we flagged it
The bill's core mechanism is deschedule cannabis and establish federal regulation, but its operative purpose is equally restorative: expungement, reinvestment in drug-war victims, and research. The character reflects both the legalization and the justice/reinvestment components that dominate the text.
What the text implies
- Federal regulatory authority over cannabis may preempt or conflict with state legalization frameworks already in place; states retain authority but federal rules on tracking, labeling, and recordkeeping could create compliance friction.
- The bill funds $1.176B in research and public health over five years but does not establish permanent funding; programs sunset or depend on future appropriations, creating uncertainty for long-term research infrastructure.
The full analysis lists 5 implications of this text.
Who stands to gain
cannabis cultivators and manufacturers (regulatory framework enables legal market); research institutions and universities (NIH grants, infrastructure funding); public health agencies (CDC, SAMHSA funding for surveillance and prevention)